Clinical trial
Multiparametric Assessment of Bone Response in mCRPC Patients Treated With Cabozantinib
NCT05265988
Study timeline
Study start (actual)2021-11-29Date precision: day
Registry last updated2024-07-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Carcinoma Prostateunresolved
Interventions
CabozantinibDRUG · verified · RxNorm: cabozantinib
Sponsors & collaborators
Alfredo Berrutilead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05265988 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.